Amigo AI, a New York–based platform for building and training patient-facing clinical AI agents, has raised $11 million in Series A funding, bringing its total raised to $17 million.
Investors
The round was led by Madrona, with participation from Optum Ventures.
Madrona is a venture capital firm based in Seattle, Washington, that focuses on early-stage technology investments. Founded in 1995, Madrona primarily invests in Seed and Series A rounds, targeting startups in cloud infrastructure, AI/ML, enterprise software, consumer internet, and robotics. The firm manages approximately $4.3 billion in assets.
Amigo AI Use of Funds
The company will use the funding to expand the development and deployment of Amigo’s clinical AI agents and scale its platform for healthcare organizations globally.
About Amigo AI
Amigo AI is a healthcare technology company that develops and trains patient-facing clinical AI agents designed to interact directly with patients across various medical workflows. Its agents support tasks such as patient intake, triage, personalized care navigation, and 24/7 patient assistance. The company partners with healthcare organizations to define their AI strategy and build custom agents that can be deployed safely at scale in more than 100 languages. Amigo AI serves healthcare organizations, including Eucalyptus, Diverge Health, and The Care Clinic.
Funding Details
Company: Amigo, Inc.
Raised: $11.0M
Round: Series A
Funding Date: March 2026
Lead Investor: Madrona
Additional Investors: Optum Ventures, General Catalyst, GSV Ventures
Company Website: https://www.amigo.ai/
Software Category: Healthcare AI / Clinical AI
Source: https://www.businesswire.com/news/home/20260310898882/en/